SCHEMBL4924708

SCHEMBL4924708

O=C1CN(c2ccc(CCCNC(=O)NC34CC5CC(CC(C5)C3)C4)cc2O)S(=O)(=O)N1.O=C1CN(c2ccc(CCCn3c(=O)[nH]c4ccccc4c3=O)cc2O)S(=O)(=O)N1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.45
EPHX1 P07099 1/20 0.45
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 3/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 2/20 0.38
UBE2N P61088 1/20 0.38
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
USP2 O75604 1/20 0.36
MAPK10 P53779 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3262018 0.87 EPHX2 (0.52) EPHX2EPHX1KMT2AALDH1A1HTT
SCHEMBL2934918 0.85 ALDH1A1 (0.47) KMT2AALDH1A1MAPK1HPGDMAPT
SCHEMBL2935066 0.82 NPC1 (0.51) EPHX2EPHX1ALDH1A1MAPK1HTT
SCHEMBL3225753 0.72 EPHX1 (0.49) EPHX1KMT2AALDH1A1HTTKDM4E
SCHEMBL3224621 0.70 PTPN1 (0.47) ALDH1A1HPGDMAPTHSD17B10KDM4E
SCHEMBL3204480 0.70 EPHX1 (0.50) EPHX2EPHX1KMT2AHPGDTP53
Carbamic Acid SCHEMBL4557656 0.69 SMN1; SMN2 (0.39) EPHX2EPHX1KMT2AALDH1A1TP53
SCHEMBL3224451 0.69 PTPN1 (0.54)
SCHEMBL3219608 0.69 PTPN1 (0.54)
SCHEMBL3220566 0.69 TRPV1 (0.47) HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008067527-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS NOVARTIS AG (CH) 2008-06-05 WO disclosed